Get the Stockscreener App
23.78
1.62%
0.38
Pre-market:
23.95
0.17
+0.71%
Progyny Inc stock is traded at $23.78, with a volume of 880.06K.
It is up +1.62% in the last 24 hours and up +8.09% over the past month.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
See More
Previous Close:
$23.40
Open:
$23.65
24h Volume:
880.06K
Relative Volume:
0.81
Market Cap:
$2.04B
Revenue:
$1.13B
Net Income/Loss:
$62.75M
P/E Ratio:
37.75
EPS:
0.63
Net Cash Flow:
$170.92M
1W Performance:
+9.33%
1M Performance:
+8.09%
6M Performance:
+4.34%
1Y Performance:
+13.02%
1-Day Range:
$23.60
$24.23
1-Week Range:
$21.26
$24.23
52-Week Range:
$13.39
$26.76
Progyny Inc Stock (PGNY) Company Profile
Name
Progyny Inc
Sector
Industry
Phone
212-888-3124
Address
1359 BROADWAY, NEW YORK, NY
Compare PGNY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
23.78 | 2.01B | 1.13B | 62.75M | 170.92M | 0.63 |
|
UNH
Unitedhealth Group Inc
|
308.49 | 275.33B | 422.82B | 22.09B | 25.27B | 23.08 |
|
CVS
Cvs Health Corp
|
70.17 | 87.01B | 386.46B | 4.49B | 4.78B | 3.58 |
|
CI
Cigna Group
|
298.32 | 79.24B | 261.22B | 5.40B | 3.94B | 18.32 |
|
ELV
Elevance Health Inc
|
309.32 | 69.71B | 189.25B | 5.35B | 5.34B | 23.50 |
|
HUM
Humana Inc
|
287.19 | 34.44B | 123.11B | 1.58B | 2.44B | 13.03 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-08-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Dec-02-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-13-24 | Downgrade | Truist | Buy → Hold |
| Sep-19-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Aug-07-24 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Aug-07-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jul-16-24 | Initiated | JMP Securities | Mkt Outperform |
| May-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Sep-27-23 | Initiated | Canaccord Genuity | Buy |
| May-22-23 | Initiated | BTIG Research | Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-05-23 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-07-22 | Initiated | Truist | Buy |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-22-21 | Downgrade | Citigroup | Buy → Neutral |
| Sep-30-21 | Initiated | Berenberg | Buy |
| Aug-12-21 | Initiated | Barclays | Overweight |
| Jun-02-21 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Mar-10-21 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Jun-02-20 | Initiated | Guggenheim | Buy |
| Nov-19-19 | Initiated | Citigroup | Buy |
| Nov-19-19 | Initiated | Goldman | Buy |
| Nov-19-19 | Initiated | JP Morgan | Overweight |
| Nov-19-19 | Initiated | Piper Jaffray | Overweight |
| Nov-19-19 | Initiated | SVB Leerink | Outperform |
View All
Progyny Inc Stock (PGNY) Latest News
Will Volume Confirm Reversal in Progyny Inc.July 2025 Macro Moves & Low Volatility Stock Recommendations - newsimpact.co.kr
Progyny (PGNY) Shares Gain 3.1% After Better-Than-Expected EarningsNews and Statistics - IndexBox
Progyny's Q2 Earnings Signal Resilience and Growth—Is the Stock a Buy Now? - AInvest
Progyny (PGNY) Stock Is Up, What You Need To Know - Yahoo Finance
Bullish Progyny Insiders Loaded Up On US$5.24m Of Stock - 富途牛牛
Why Progyny (PGNY) Is Up 7.6% After Raising 2025 Revenue and Earnings Guidance - simplywall.st
Trendlines Suggest Progyny Inc. May Bottom Out SoonMarket Movers & Capital Efficiency Focused Strategies - newsyoung.net
Will Progyny Inc. outperform during market ralliesWeekly Stock Report & Momentum Based Trading Signals - classian.co.kr
How Progyny Inc. stock performs during market volatilityInflation Watch & Reliable Momentum Entry Alerts - newsyoung.net
Is Progyny Inc. stock a smart retirement pick2025 Performance Recap & Weekly High Potential Alerts - thegnnews.com
Is It Too Early to Call Recovery in Progyny Inc.Weekly Trade Review & Free Real-Time Volume Trigger Notifications - metal.it
Can Progyny Inc. Escape Recent Bear ChannelWeekly Trend Recap & Accurate Entry/Exit Alerts - sundaytimes.kr
Can a trend reversal in Progyny Inc. lead to recoveryJuly 2025 PostEarnings & Verified Short-Term Plans - Newser
Advanced analytics toolkit walkthrough for Progyny Inc.Weekly Investment Summary & Free Real-Time Volume Trigger Notifications - Newser
What’s next for Progyny Inc. stock priceMarket Sentiment Report & Real-Time Chart Pattern Alerts - Newser
Progyny stock plunges 18% amid lowered guidance, Truist downgrade - MSN
PNC Financial Services Group Inc. Cuts Stock Position in Progyny, Inc. (NASDAQ:PGNY) - Defense World
Progyny Inc. Approaches Support With Recovery in Sight2025 Trading Volume Trends & Long-Term Growth Plans - newsyoung.net
LVBCH choses women’s health services partner - Lehigh Valley Business
5 Must-Read Analyst Questions From Progyny’s Q2 Earnings Call - Yahoo Finance
Will Progyny Inc. Sustain Its Chart BreakoutPortfolio Performance Report & Daily Chart Pattern Signals - newsimpact.co.kr
Director Cashes In on Progyny Stock Sale! - TipRanks
Progyny Director Sells 2,500 Shares at $22.04 on August 11, 2023. - AInvest
Progyny (PGNY) director Gordon sells $55k in shares By Investing.com - Investing.com Canada
Progyny (PGNY) director Gordon sells $55k in shares - Investing.com
NeoGenomics, Progyny, Repligen, Revvity, and Waters Corporation Shares Are Soaring, What You Need To Know - Yahoo Finance
Progyny’s Earnings Call Highlights Robust Growth and Strategic Partnerships - MSN
Progyny raises full-year 2025 revenue guidance to $1.27B as member engagement and product expansion accelerate - MSN
Cetera Investment Advisers Acquires Shares of 42,313 Progyny, Inc. (NASDAQ:PGNY) - Defense World
Volatility clustering patterns for Progyny Inc.July 2025 PreEarnings & Stock Portfolio Risk Control - Newser
PGNY Q2 Deep Dive: Product Expansion and Client Diversification Drive Upbeat Guidance - Yahoo Finance
Natixis Advisors LLC Raises Stock Holdings in Progyny, Inc. (NASDAQ:PGNY) - Defense World
Progyny Exceeds Earnings Expectations, Analysts Expect Continued Growth in 2025 - AInvest
Progyny's Q2 2025 Earnings Call: Unpacking Contradictions in Sales Performance, Pricing Impact, and Margin Expectations - AInvest
Progyny, Inc. Just Beat EPS By 12%: Here's What Analysts Think Will Happen Next - Yahoo Finance
Price momentum metrics for Progyny Inc. explainedFree Breakout Momentum Picks With Protection - Newser
Progyny, Inc. Reports Record Q2 2025 Revenue - TipRanks
Progyny Analyst Verdict: Bullish Sentiment Dominates - AInvest
What makes Progyny Inc. stock price move sharplyTechnical Long-Term Outlook and Recap Guide - Newser
Using R and stats models for Progyny Inc. forecastingChart Based Entry Tool for ROI Traders - Newser
Why Progyny Inc. stock attracts strong analyst attentionFuture Growth Stock Forecasting Strategy - Newser
Is Progyny Inc. a defensive stockFast Payout Trading Plans - newsyoung.net
A Quick Look at Today's Ratings for Progyny(PGNY.US), With a Forecast Between $28 to $30 - 富途牛牛
Progyny, Inc. (NASDAQ:PGNY) Q2 2025 Earnings Call Transcript - Insider Monkey
Progyny 2025 Q2 Earnings Net Income Grows 3.8% Despite Stock Sell-Off - AInvest
Can Progyny Inc. deliver consistent dividendsWealth Catalysts in Stocks - thegnnews.com
Progyny (NASDAQ:PGNY) Shares Gap Up After Analyst Upgrade - Defense World
PGNY News Today | Why did Progyny stock go down today? - MarketBeat
Progyny Outpaces Expectations And Lifts 2025 Outlook - Finimize
Cantor Fitzgerald reiterates Overweight rating on Progyny stock By Investing.com - Investing.com South Africa
Progyny, Inc. shares fall 3.64% intraday despite Q2 earnings beat and Q3 guidance. - AInvest
Progyny Inc Stock (PGNY) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.59%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):